Announcements Trials
Browse Landscape

Status

Withdrawn 1Completed 1

Sponsor Class

OTHER 8NIH 2INDUSTRY 2NETWORK 1

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Lymphoid 2

Conditions

Neoplasms 172Breast Neoplasms 102Prostatic Neoplasms 45Lung Neoplasms 42Lymphoma 37Leukemia 35Brain Neoplasms 35Melanoma 29Ovarian Neoplasms 24Lymphoma, Non-Hodgkin 20Stomach Neoplasms 18HIV Infections 17Colonic Neoplasms 17Esophageal Neoplasms 16Carcinoma, Non-Small-Cell Lung 16Urinary Bladder Neoplasms 15Glioma 15Acquired Immunodeficiency Syndrome 15Sarcoma, Kaposi 14Neoplasm Metastasis 14Leukemia, Myeloid, Acute 14Thyroid Neoplasms 13Precursor Cell Lymphoblastic Leukemia-Lymphoma 13Kidney Neoplasms 13Hematologic Neoplasms 13Endometrial Neoplasms 13Colorectal Neoplasms 13Uterine Cervical Neoplasms 12Sarcoma 12Neurofibromatosis 1 12

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NIH × Observational × Lymphadenopathy × Clear all
NCT01672918 2019-12-05

Fluorodeoxyglucose Imaging Studies to Detect Lymphoma

National Institutes of Health Clinical Center (CC)

Withdrawn
Lymphoid

Lymphadenopathy, Lymphoma, Autoimmune Lymphoproliferative Syndrome

NCT00068146 2018-07-05

Fluorodeoxyglucose-Positron Emission Tomography (FDG-PET) to Evaluate Autoimmune Lymphoproliferative Syndrome (ALPS) and ALPS-associated Lymphoma

National Institutes of Health Clinical Center (CC)

Completed
77 enrolled
Lymphoid

Lymphadenopathy, Lymphoma, Lymphoproliferative Disorders, Syndrome, Genetic Diseases, Inborn

Data powered by HemOnc (CC BY 4.0) Colophon âš¡